Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Predictors of Conduction Disturbances Requiring a Late Permanent Pacemaker

This analysis shows that baseline right bundle branch block and increased PR length after transcatheter aortic valve replacement (TAVR) are independent predictors of advanced conduction disturbances requiring late pacemaker implantation. A simple electrocardiography can detect these potentially fatal conduction disturbances that might happen more than 48 hours after TAVR.

Data from consecutive TAVR patients from one center (Milan, Italy) were gathered between 2007 and 2015. Delta PR and delta QRS were defined as the difference between the last PR and QRS length available 48 hrs. after TAVR and baseline PR and QRS length.

 

The study looked at data from 740 patients, excluding 78 that already had a pacemaker and 51 that had received one less than 48 hrs. after TAVR, which left 611 patients for final analysis.

 

8.8% developed conduction disturbances requiring a pacemaker ≥48h after procedure. Patients requiring late pacemaker implantation had wider QRS (113 ± 25 ms vs. 105 ± 23 ms; p=0.009), higher prevalence of right bundle branch block (12.9% vs. 5.3%; p=0.026) and were more likely to receive a self-expandable valve (51.8% vs. 31.9%; p=0.003).


Read also: EXCEL Sub-Analysis: Angioplasty vs. Surgery in Chronic Renal Insufficiency.


Delta PR was 40 ± 51 ms (p=0.0001) and delta QRS was 22 ± 61 ms (p=0.001).

 

Multivariable analysis showed that baseline right bundle branch block had between 3.5 and 4 times higher risk of getting a pacemaker (p=0.0001) and delta PR increased this risk by 1.3 times every 10 ms (p=0.0001).

 

Conclusion

The evidence consolidates in favor of a simple ECG to detect patients at higher risk of requiring late pacemaker implantation after TAVR. Baseline bundle branch block and increased PR are predictors of late advanced conduction disturbances.

 

Original title: Predictors of Advanced Conduction Disturbances Requiring a Late (≥48 hs) Permanent Pacemaker Following Transcatheter Aortic Valve Replacement.

Reference: Antonio Mangieri et al. J Am Coll Cardiol Intv 2018;11:1519–26.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

TAVI in TAVI: Clinical and Hemodynamic Outcomes According to the Type of Prosthesis Used in TAVI-in-TAVI

With the expansion of TAVI to younger and lower surgical risk patients, bioprosthetic valve degeneration and the need for repeat interventions are expected to...

Percutaneous Closure of Patent Foramen Ovale in Patients Over 60 Years Old With Cryptogenic Stroke: A Safe and Effective Strategy?

Cryptogenic stroke accounts for up to one-third of all ischemic strokes and remains strongly associated with the presence of a patent foramen ovale (PFO),...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...